Chinese experience on comparison of clinical efficacy and safety of hemodialysis and peritoneal dialysis in the treatment of diabetic kidney failure: a systematic review and meta-analysis

Bibliographic Details
Title: Chinese experience on comparison of clinical efficacy and safety of hemodialysis and peritoneal dialysis in the treatment of diabetic kidney failure: a systematic review and meta-analysis
Authors: Zhifeng Wei, Yujie Jin, Jinxiu Cheng, Xiaoli Han, Junfen Liu, Shengjun Liu
Source: Frontiers in Medicine, Vol 10 (2023)
Publisher Information: Frontiers Media S.A., 2023.
Publication Year: 2023
Collection: LCC:Medicine (General)
Subject Terms: hemodialysis, peritoneal dialysis, kidney failure, safety, efficacy, Medicine (General), R5-920
More Details: ObjectiveThis meta-analysis aims to compare the efficacy and safety of peritoneal dialysis (PD) and hemodialysis (HD) in the treatment of diabetic kidney failure.MethodsFive databases were selected to retrieve research on PD and HD for diabetic kidney failure until 6 August 2022. A fixed-effects or random-effects model was utilized to calculate the standardized mean difference (SMD) or odds ratio (OR) based on the heterogeneity among studies.ResultsSixteen studies were included. The results showed that patients with diabetic kidney failure treated with PD had lower levels of albumin, total protein, and systolic blood pressure (SBP) and higher levels of urine volume, creatinine, and blood urea nitrogen (BUN) and lower risk of cardiovascular and bleeding events, with significant statistical difference when compared with patients treated with HD (albumin: SMD = −1.22, 95%CI: −1.53, −0.91; total protein: SMD = −0.96, 95%CI: −1.16, −0.77; SBP: SMD = −0.35, 95%CI: −0.64, −0.06; urine volume: SMD = 0.68, 95%CI: 0.40, 0.96; creatinine: SMD = 0.49, 95%CI: 0.27, 0.72; BUN: SMD = 0.55, 95%CI: 0.25, 0.85; cardiovascular events: OR = 0.42, 95%CI: 0.28, 0.62; bleeding: OR = 0.41, 95%CI 0.27, 0.62).ConclusionThis meta-analysis summarized the advantages and disadvantages of PD and HD for treating diabetic kidney failure patients. Compared with HD, PD is more effective in preserving residual kidney function, reducing hemodynamic effect, and lowering the risk of bleeding and cardiovascular events in diabetic kidney failure patients, but it also predisposes to protein-energy malnutrition and increases the risk of infection.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2296-858X
Relation: https://www.frontiersin.org/articles/10.3389/fmed.2023.1116103/full; https://doaj.org/toc/2296-858X
DOI: 10.3389/fmed.2023.1116103
Access URL: https://doaj.org/article/3ee9121db8734f9bbf59daa15607c2c7
Accession Number: edsdoj.3ee9121db8734f9bbf59daa15607c2c7
Database: Directory of Open Access Journals
More Details
ISSN:2296858X
DOI:10.3389/fmed.2023.1116103
Published in:Frontiers in Medicine
Language:English